McCloskey EV - Search Results

1

A reference standard for the description of osteoporosis.

Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd, Khaltaev N. Kanis JA, et al. Among authors: mccloskey ev. Bone. 2008 Mar;42(3):467-75. doi: 10.1016/j.bone.2007.11.001. Epub 2007 Nov 17. Bone. 2008. PMID: 18180210 Review.

2

Epidemiology of vertebral osteoporosis.

Kanis JA, McCloskey EV. Kanis JA, et al. Among authors: mccloskey ev. Bone. 1992;13 Suppl 2:S1-10. doi: 10.1016/8756-3282(92)90189-4. Bone. 1992. PMID: 1385718 Review.

3

Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption.

Taube T, Beneton MN, McCloskey EV, Rogers S, Greaves M, Kanis JA. Taube T, et al. Among authors: mccloskey ev. Eur J Haematol. 1992 Oct;49(4):192-8. doi: 10.1111/j.1600-0609.1992.tb00046.x. Eur J Haematol. 1992. PMID: 1464362

4

Osteoporotic fractures: an unusual presentation of haemochromatosis.

Eyres KS, McCloskey EV, Fern ED, Rogers S, Beneton M, Aaron JE, Kanis JA. Eyres KS, et al. Among authors: mccloskey ev. Bone. 1992;13(6):431-3. doi: 10.1016/8756-3282(92)90086-c. Bone. 1992. PMID: 1476821

5

Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate).

Eyres KS, Marshall P, McCloskey E, Douglas DL, Kanis JA. Eyres KS, et al. Drug Saf. 1992 Mar-Apr;7(2):162-5. doi: 10.2165/00002018-199207020-00008. Drug Saf. 1992. PMID: 1605902

6

Stanozolol stimulates remodelling of trabecular bone and net formation of bone at the endocortical surface.

Benéton MN, Yates AJ, Rogers S, McCloskey EV, Kanis JA. Benéton MN, et al. Among authors: mccloskey ev. Clin Sci (Lond). 1991 Oct;81(4):543-9. doi: 10.1042/cs0810543. Clin Sci (Lond). 1991. PMID: 1657503

7

Treatment of skeletal disease in breast cancer with clodronate.

Paterson AH, Ernst DS, Powles TJ, Ashley S, McCloskey EV, Kanis JA. Paterson AH, et al. Among authors: mccloskey ev. Bone. 1991;12 Suppl 1:S25-30. doi: 10.1016/8756-3282(91)90063-o. Bone. 1991. PMID: 1720012 Review.

8

Rationale for the use of bisphosphonates in bone metastases.

Kanis JA, McCloskey EV, Taube T, O'Rourke N. Kanis JA, et al. Among authors: mccloskey ev. Bone. 1991;12 Suppl 1:S13-8. doi: 10.1016/8756-3282(91)90061-m. Bone. 1991. PMID: 1954047 Review.

9

Use of diphosphonates in hypercalcaemia due to malignancy.

Kanis JA, McCloskey EV, Paterson AH. Kanis JA, et al. Among authors: mccloskey ev. Lancet. 1990 Jan 20;335(8682):170-1. Lancet. 1990. PMID: 1967461 No abstract available.

10

Effects of amino-butylidene diphosphonate in hypercalcemia due to malignancy.

Bickerstaff DR, O'Doherty DP, McCloskey EV, Hamdy NA, Mian M, Kanis JA. Bickerstaff DR, et al. Among authors: mccloskey ev. Bone. 1991;12(1):17-20. doi: 10.1016/8756-3282(91)90049-o. Bone. 1991. PMID: 2054231

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

511 results

Search Page